Latest Cover
Practical Diabetes is a journal for healthcare professionals covering all aspects of diabetes care including type 1 and type 2 diabetes, obesity, new insulins and type 2 drugs, guidelines and policy issues and diabetes complications.
In the 2016 Health Readership Survey of Senior Doctors and Consultants in diabetes, Practical Diabetes was the most highly read diabetes journal with 86% of Consultants reading the journal in the last 12 months.

Latest News

Medication ‘way to avoid lifestyle change’

People with diabetes admit they are reluctant to alter their lifestyle to improve glycaemic control and say medication is a way of avoiding change, according...Read more

Metformin OK’d for moderate renal impairment

The EU is set to approve the use of metformin in patients with moderately impaired kidney function (glomerular filtration rate 30–59 ml/min). The move is...Read more

Do DPP4 inhibitors protect against nephropathy?

Saxagliptin may have a protective effect against kidney disease in people with type 2 diabetes, an analysis of the SAVOR-TIMI 53 trial suggests. The study...Read more

Diabetes ‘prescribing hotspots’ identified

Seven of the ten areas in England with highest rates of prescribing of glucose-lowering drugs are in the East Midlands or London, according to an analysis of...Read more

Boyhood obesity will increase in deprived areas

By 2020, 43 per cent of boys in the most deprived families in the UK will be obese, according to the Obesity Health Alliance (OHA), but obesity and overweight...Read more

All SGLT2 inhibitors to be recommended for triple therapy

NICE is finally bringing its guidance on dapagliflozin in line with the other SGLT2 inhibitors, empagliflozin and canagliflozin. The two newer agents were...Read more

Novel combinations for type 2 diabetes

Clinical trials have demonstrated that novel combinations of GLP-1 agonists with other glucose-lowering therapies are superior to their component drugs. Three...Read more

Featured Articles

Is diabetes still a state of premature cardiovascular death?
The association between diabetes and cardiovascular disease is now well accepted. For the Arnold Bloom lecture 2016 I described the great improvements in the management of cardiovascular disease that have occurred in the last 20 years in people with diabetes.
Click here to view

SUSTAIN-6: cardiovascular safety of a once-weekly GLP-1 receptor agonist
To establish cardiovascular safety prior to regulatory approval, pharmaceutical sponsors are mandated to demonstrate that any new antidiabetic drug does not result in an unacceptable increase in cardiovascular risk. This can be done either by including patients at high vascular risk in the phase…
Click here to view

Time to take control: diabetes in England 2016
Diabetes UK sets out the current state of diabetes services in England in its new report, State of the Nation 2016. It reveals wide variations in care and poor deliv­ery of life-changing educational support, leading to devastating complications for many of the more than three…
Click here to view

Web design and marketing agency Leamington Spa